Silencing of PIGU inhibits the progression of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway

J Ji Zuo (Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University) H Haiyang Guo G Guangbing Hu Y Yuman HE Y Yong Tang (Ensem Therapeutics, Inc., 200 Boston Ave., Medford, Massachusetts 02155, United States) J Jie Li Y Yutong Cui S Shiqi Liang X Xinrui Chen Z Zichen Luo X Xiaobo Wang X Xianfei Wang

Article Details

Volume / Issue Vol. 15, Issue 1
Published August 25, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (12)

J

Ji Zuo

Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University

H

Haiyang Guo

G

Guangbing Hu

Y

Yuman HE

Y

Yong Tang

Ensem Therapeutics, Inc., 200 Boston Ave., Medford, Massachusetts 02155, United States

J

Jie Li

Y

Yutong Cui

S

Shiqi Liang

X

Xinrui Chen

Z

Zichen Luo

X

Xiaobo Wang

X

Xianfei Wang